Abstract
STLV-1, Simian T-Cell Lymphotropic Virus type 1, shares genomic similarity with HTLV-1, making it a relevant model for genome editing studies. CRISPR-Cas9 technology has been crucial in genetic editing of HIV-1, but there is a scarcity of studies applying this strategy to the HTLV-1 genome. Furthermore, investigating cGAS/STING activation pathways can provide insights into inflammation an…